More Technology stocks
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Kimball Electronics is a contract electronics manufacturer (EMS) providing engineering, manufacturing, and supply chain services across automotive, medical, and industrial end markets. The company operates manufacturing facilities in the US, Mexico, Poland, Romania, Thailand, and China, serving Tier 1 OEMs with complex, regulated products requiring high reliability. Recent revenue contraction reflects automotive sector destocking and medical device customer inventory adjustments, though strong FCF generation (24.6% yield) indicates operational discipline.
Kimball operates on a contract manufacturing model with razor-thin gross margins (7.0%) typical of EMS providers. Revenue comes from per-unit manufacturing fees plus material pass-through costs. Profitability depends on operational efficiency, capacity utilization (fixed cost absorption), and supply chain management. The company competes on engineering capabilities for complex assemblies, geographic footprint proximity to customers, and quality certifications (ISO 13485 medical, IATF 16949 automotive). Limited pricing power as customers can switch EMS providers, though switching costs increase with design complexity and regulatory requirements. Operating leverage is moderate - fixed facility costs require 75-80% capacity utilization for profitability.
Automotive production volumes and inventory cycles - OEM build rates directly drive assembly demand, particularly for electric vehicle electronics content
Medical device customer order patterns - large program wins or losses with Tier 1 medical OEMs materially impact revenue mix
Capacity utilization rates across manufacturing footprint - operating margins expand significantly above 80% utilization
New program ramps and design wins - multi-year contracts with automotive/medical OEMs provide revenue visibility
Supply chain disruption and component availability - semiconductor shortages and logistics costs impact margins
Automotive electrification transition risk - shift to EVs changes electronics content and supplier relationships, with risk of being designed out of next-generation platforms if engineering capabilities don't evolve
EMS margin compression - ongoing commoditization of contract manufacturing services as Chinese competitors expand capabilities and customers consolidate supplier bases to extract pricing concessions
Reshoring and geopolitical manufacturing shifts - US-China trade tensions and supply chain localization mandates may require costly facility relocations or duplicate capacity investments
Competition from larger EMS providers (Flex, Jabil, Sanmina) with greater scale economies and broader service offerings that can bundle engineering, manufacturing, and aftermarket services
Customer vertical integration - large automotive OEMs bringing electronics manufacturing in-house to control costs and intellectual property, particularly for strategic EV components
Low switching costs for customers on mature programs - once products are designed and qualified, customers can rebid manufacturing to lowest-cost provider
Working capital volatility - rapid revenue declines (-13.3% YoY) create inventory obsolescence risk and potential customer payment delays if OEMs face financial stress
Geographic concentration risk - manufacturing footprint in Mexico, Poland, Romania, Thailand, and China exposes company to currency fluctuations, labor cost inflation, and regulatory changes across multiple jurisdictions
Capex requirements for new program ramps - winning new automotive or medical programs requires upfront tooling and equipment investments before revenue materializes, straining cash flow during transition periods
high - Automotive exposure (>50% of revenue) makes Kimball highly sensitive to vehicle production cycles, which correlate strongly with GDP growth and consumer durables spending. Industrial electronics demand tracks capital equipment spending and manufacturing activity. Medical device segment provides some counter-cyclical stability but represents smaller revenue portion. Current -13.3% revenue decline reflects cyclical downturn in automotive sector inventory destocking.
Rising interest rates negatively impact Kimball through two channels: (1) automotive demand destruction as vehicle financing costs increase, reducing OEM production volumes, and (2) customer capital equipment spending delays in industrial segments. However, the company's modest debt load (0.27 D/E) limits direct financing cost impact. Valuation multiples compress as investors rotate away from cyclical industrials during rate hiking cycles.
Moderate credit sensitivity. Kimball extends payment terms to large OEM customers (typical 60-90 day DSO) and requires supplier financing for component purchases. Tightening credit conditions can stress working capital and reduce customer order volumes as end-market financing becomes constrained. However, strong current ratio (1.83x) and positive FCF provide buffer against credit market disruptions.
value - Stock trades at 0.4x sales and 1.1x book value with 24.6% FCF yield, attracting deep value investors betting on cyclical recovery. Recent 43% one-year return suggests momentum players entered on turnaround thesis, but -8.9% three-month decline indicates profit-taking. Not suitable for growth investors given -13.3% revenue contraction. No dividend mentioned, so not income-focused.
high - Small-cap industrials with concentrated customer base and cyclical end markets exhibit elevated volatility. EMS stocks typically trade with beta >1.2 to broader market. Revenue lumpiness from program timing and quarterly margin swings from capacity utilization changes drive earnings volatility. Recent 43% annual return followed by -8.9% quarterly decline demonstrates characteristic volatility pattern.
